Journals / Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi / 2009 / Cilt: 12 - Sayı: 3

Over kanseri sonrasında gelişen anti-yo negatif paraneoplastik serebellar dejenerasyon: Olgu sunumu ve literatür özeti

Anti-yo negative paraneoplastic cerebellar degeneration following ovarian carcinoma: A case report and review of the literature

Pages
122–125
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, it was aimed to increase our knowledge about this rare syndrome by investigating 55 years old female patient with PCD after ovarian cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Paraneoplastic syndromes are disorders of organs or tissues that occur at a site distant from primary cancer or its metastases.
📊
Key Findings & Data:Paraneoplastic cerebellar degeneration (PCD) is a rare and unusual non-metastatic neurolojic complication as a remote effect of cancer.
💡
Conclusion & Impact:In this case report, it was aimed to increase our knowledge about this rare syndrome by investigating 55 years old female patient with PCD after ovarian cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Paraneoplastic syndromes are disorders of organs or tissues that occur at a site distant from primary cancer or its metastases. Paraneoplastic cerebellar degeneration (PCD) is a rare and unusual non-metastatic neurolojic complication as a remote effect of cancer. Clinically it is characterized by subacute onset by progressive pancerebellar dysfunction including truncal and gait ataxia, dysartria and nystagmus. Although the role of these antibodies in the mechanisms of PCD remains unknown, the detection of these antibodies in serum of patients suspected of PCD often lead to a focused search for the underlying neoplasms. In this case report, it was aimed to increase our knowledge about this rare syndrome by investigating 55 years old female patient with PCD after ovarian cancer.

Özet

Paraneoplastik sendromlar primer kanserden veya metastazlarından uzak olan bir bölgede organları veya dokularda görülen hastalıklardır. Paraneoplastik serebellar dejenerasyon( PSD) ise kanserin uzak etkisi olarak nadir görülen non metastatik nörolojik komplikasyonudur. Klinik olarak gövde ve yürüyüş ataksisi, dizartri ve nistagmusu içeren subakut fakat pogresif panserebellar disfonksiyon ile karakterizedir. PSD'nin mekanizmasındaki rolü tam olarak bilinmese de bu antikorların serumda tespit edilmesi altta yatan kanserin araştırılmasında yol gösterici olmaktadır. Bu olgu sunumunda over kanseri sonrası PSD gelişen 55 yaşındaki bayan hastayı inceleyerek nadir görülen bu sendrom hakkında bilgilerimizi arttırmayı amaçladık.

🔖

Cite This Article

AKARSU, S., TOK, F., YAŞAR, E., BALABAN, B., ALACA, R. (2009). Over kanseri sonrasında gelişen anti-yo negatif paraneoplastik serebellar dejenerasyon: Olgu sunumu ve literatür özeti. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, Cilt: 12 - Sayı: 3, 122–125. https://ajindex.com/articles/193405

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Yarbro J, Bomstein R, Mastrangelo M. A comprehensive review of all paraneoplastic syndromes.: Paraneoplastic syndromes. Semin Onco 1997; 24:265-385
  2. Brain L, Norris FH (Eds): Contemporary Neurology Symposia, vol 1. New York and London: Grune & Stratton; 1965
  3. Brouwer B, Biemond A. Les affection parenchymateuse ducervelet et leur signification de cat orgsne. J Beige de Neurol Psychiatr 1938;38:691-757
  4. Henson RA, Urich H: Cancer and the nervous system: the neurological manifestations of systemic malignant disease. London: Blackwell Scientific; 1982
  5. Mason W, Graus F, Lang B, Honnorat J, Delattre J-Y, Valldeoriola F, Antoine J, Rosenblum M, Rosanfeld M, Newsom-Davis J et al. Small-call lung cancer, paraneoplastic cerebellar degeneration end the Lambert-Eaton myasthenic syndrome. Brain 1997;120:1279-300
  6. Denny-Brown D: Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 1948;11:73-87
  7. Hall DJ, Dyer ML, Parker JC Jr. Ovarian cancer complicated by cerebellar degeneration: a paraneoplastic syndrome. Gynecol Oncol 1985;21:240-6
  8. Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 1988;24:559-67
  9. Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 1983;14:609-13
  10. Lennon VA. The case for a descriptive generic nomenclature: clarification of immunostaining criteria for PCA-1, ANNA-1, and ANNA-2 autoantibodies. Neurology 1994;44:2412-5
  11. Graus F, Dalmau J, Valldeoriola F, Ferrer I, Reñe R, Marin C, Vecht CJ, Arbizu T, Targa C, Moll JW. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997;74:55-61
  12. Santillan A, Bristow RE. Paraneoplastic cerebellar degeneration in a woman with ovarian cancer. Nat Clin Pract Oncol 2006;3:108-12; quiz 1 p following 112
  13. Odell W. A review of paraneoplastic endocrine disorders. Metabolic syndromes of cancer. Semin Oncol 1997; 24:299-317
  14. Denny-Brown D: Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 1948;11:73-87
  15. Lang B, Vincent A. Autoimmunity to ion-channels and other proteins in per,neoplastic disorders. Curr Opin Immunol 1996;8:865-71
  16. Drlicek M, Bianchi G, Bogliun G, Casati B, Grisold W, K